These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6280495)

  • 21. [Role of the B lymphocytes in children with infectious mononucleosis caused by Epstein-Barr Virus].
    Luo XM; Zhou FY; Zhou YL; Wang XX; Qiu LN
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):701-4. PubMed ID: 15482676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.
    Montel AH; Morse PA; Brahmi Z
    Cell Immunol; 1995 Jan; 160(1):104-14. PubMed ID: 7531116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient immune deficiency in patients with acute Epstein-Barr virus infection.
    Junker AK; Ochs HD; Clark EA; Puterman ML; Wedgwood RJ
    Clin Immunol Immunopathol; 1986 Sep; 40(3):436-46. PubMed ID: 3015461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P; Ernberg I; Klein G; Steinitz M
    Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS
    J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
    J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients.
    Klein G; Svedmyr E; Jondal M; Persson PO
    Int J Cancer; 1976 Jan; 17(1):21-6. PubMed ID: 55396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
    Kaplan J; Shope TC
    Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV; Keightley RG
    Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T and B lymphocytes in peripheral blood of children with infectious mononucleosis and tonsillitis.
    Resková D; Kubiková A; Macku M
    Acta Paediatr Acad Sci Hung; 1980; 21(1):27-31. PubMed ID: 6255733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.
    Schooley RT; Haynes BF; Grouse J; Payling-Wright C; Fauci AS; Dolin R
    Blood; 1981 Mar; 57(3):510-7. PubMed ID: 6257313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.